ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 69 filers reported holding ARCELLX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,687,101 | +10.1% | 102,762 | -2.9% | 0.40% | +17.5% |
| Q2 2023 | $3,347,356 | -45.0% | 105,862 | -46.4% | 0.34% | -48.6% |
| Q1 2023 | $6,084,297 | -17.1% | 197,478 | -16.7% | 0.66% | -11.8% |
| Q4 2022 | $7,341,578 | -48.1% | 236,978 | -68.6% | 0.74% | -50.6% |
| Q3 2022 | $14,149,000 | -32.5% | 753,833 | -35.3% | 1.51% | -42.1% |
| Q2 2022 | $20,953,000 | +26.1% | 1,165,533 | -3.7% | 2.60% | +106.2% |
| Q1 2022 | $16,619,000 | – | 1,209,876 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |